Long-term antibody response following SPUTNIK V primary vaccination in healthcare workers with and without history of SARS-CoV-2 infection: Prospective cohort study from a hospital in Argentina

BACKGROUND: In December 2020, Sputnik V was incorporated to the National COVID-19 Immunization Plan in Argentina. Studies had shown 98% of antibody response rate. To date, data on immunogenicity and antibody persistence in Argentina are scarce. The objective was to assess humoral immune response aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Gentile, A., Castellano, V.E., Pacchiotti, A., Weinberger, N., Diana Menéndez, S., del Pino, M., Carciofi, G., Lamy, P., Mistchenko, A.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Regular paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213035/
https://www.ncbi.nlm.nih.gov/pubmed/35755140
http://dx.doi.org/10.1016/j.jvacx.2022.100187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213035/
https://www.ncbi.nlm.nih.gov/pubmed/35755140
http://dx.doi.org/10.1016/j.jvacx.2022.100187

Ejemplares similares